Indirin

Sydenham Laboratories, Inc.🇵🇭 Food and Drug Administration - Philippines

Approval Id: 1cede8e0c6e85801
Drug Approval Philippines Name: Indirin
Product Name: Indirin
Registration Number: DR-XY46106
Brand Name: Indirin
Generic Name: Propranolol Hydrochloride
Dosage Form: Film-Coated Tablet
Dosage Strength: 40 mg
Manufacturer: Sydenham Laboratories, Inc.
Trader: Medchoice Endocrine Group, Inc.
Issuance Date: 24 June 2022
Expiry Date: 18 October 2027
Pharmacologic Category: Antihypertensive/Anti-Angina (Beta-Adrenoreceptor Blocker)
Classification: Prescription Drug (RX)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

1cede8e0c6e85801

Type

Standard